Tag Archives: HUM

Top 10 Undervalued Stocks To Invest In 2018

Our primary purpose is to assist subscribers in growing their capital and income base to generate cash for their current and future needs, explains Kelley Wright, editor of Investment Quality Trends.

To that end we believe that shares of high quality stocks purchased at a historically repetitive area of low-price/high-yield offers the greater potential for downside protection and upside appreciation.

The Timely Ten, therefore, is not just another ‘best of, right now’ list.  Rather, it is our reasoned expectation — based on our methodology and experience — that these ten currently Undervalued stocks offer the greatest real total-return potential over the next five years.

Whether you are building a portfolio from scratch, are partially invested and seeking new positions, or are fully invested and in need of some affirmation and hand holding, The Timely Ten represents our top ten current recommendations.

Top 10 Undervalued Stocks To Invest In 2018: ENGlobal Corporation(ENG)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested shorting small cap energy engineering and professional services stock ENGlobal Corp (NASDAQ: ENG):

Top 10 Undervalued Stocks To Invest In 2018: Hudson Pacific Properties, Inc.(HPP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on Friday.

    Douglas Dynamics Inc (NYSE: PLOW) – $0.2350 dividend, 2.9183 percent yield
    Tiffany & Co. (NYSE: TIF) – $0.4500 dividend, 2.6758 percent yield
    PulteGroup, Inc. (NYSE: PHM) – $0.0900 dividend, 1.7078 percent yield
    Leidos Holdings, Inc. (NYSE: LDOS) – $0.3200 dividend, 3.0851 percent yield
    Tupperware Brands Corporation (NYSE: TUP) – $0.6800 dividend, 4.1756 percent yield
    Hudson Pacific Properties Inc (NYSE: HPP) – $0.2000 dividend, 2.36

Top 10 Undervalued Stocks To Invest In 2018: Columbia Sportswear Company(COLM)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows mid cap Under Armourpreviously outperforming peers like large cap Nike Inc (NYSE: NKE) and mid cap Columbia Sportswear Company (NASDAQ: COLM), but that outperformance slipped late last year:

  • [By Matt Hogan]

    SKX is also highly attractive in a relative basis when compared to several of its publicly traded peers: Foot Locker, Inc. (NYSE: FL), Deckers Outdoor Group (NYSE: DECK), Wolverine World Wide, Inc. (NYSE: WWW) and Columbia Sportswear Company (NASDAQ: COLM). The company's forward EBITDA multiple of 6.9x is equal or below all of the comparable companies: FL (6.9x), DECK (7.6x), WWW (10.1x) and COLM (10.8x).

  • [By D.R. Barton, Jr.]

    I bring Mr. Houdini up today because when I look at our favorite “Pop & Drop” play – Columbia Sportswear Co. (Nasdaq: COLM) – I find an eerie similarity to this great “escapesman.”

  • [By Ben Levisohn]

    Looking at recent historical deals, we arrive at a $18-$23 potential deal range. We analyzed transactions that have been announced over the past four years and involved companies catering to a higher income customer. These deals include Southern Tide (acquired by Oxford Industries (OXM)), Joe’s Jeans (acquired by Sequential Brands Group (SQBG)), prAna (acquired by Columbia Sportswear (COLM)), The Jones Group (acquired by Sycamore Partners [private] and Juicy Couture (acquired by Authentic Brands Group [private]). The average EV/EBITDA multiple of these transactions are 12.9x (in line with KATE’s 5-year historical average of 12.1x) and implies a potential deal range of $22-$23. When taking the average of recent (F13-16) deals implies an ~10.5x EV/EBITDA multiple. When applying the ~10.5x multiples to KATE’s trailing EBITDA, we arrive at an $18- $19 potential share price.

Top 10 Undervalued Stocks To Invest In 2018: RAIT Financial Trust(RAS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of RAIT Financial Trust (NYSE: RAS) were down 9 percent to $1.09. FBR Capital downgraded RAIT Financial Trust from Buy to Neutral.

    Rave Restaurant Group Inc (NASDAQ: RAVE) was down, falling around 18 percent to $1.65. RAVE Restaurant reported a $5 million equity rights offering.

Top 10 Undervalued Stocks To Invest In 2018: Diodes Incorporated(DIOD)

Advisors’ Opinion:

  • [By Jim Robertson]

    Small capsemiconductor stock Diodes Incorporated (NASDAQ: DIOD) has produced a double top on its technical chart with shares just below breakout levels:

Top 10 Undervalued Stocks To Invest In 2018: iShares PHLX SOX Semiconductor Sector Index Fund(SOXX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group along with peersSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX)all taking offlast year albeit MRVL has underperformed ETF benchmarks:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group under performingpeersSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX)will all taking offlast year:

  • [By Peter Graham]

    A long term performance chart shows Marvell Technology Group in an uptrend for the past two year, but also under performingpeerSTMicroelectronics NV (NYSE: STM) and ETF benchmarks SPDR S&P Semiconductor ETF (NYSEARCA: XSD) and iShares PHLX SOX Semiconductor Sector (NASDAQ: SOXX):

Top 10 Undervalued Stocks To Invest In 2018: Datawatch Corporation(DWCH)

Advisors’ Opinion:

  • [By Lisa Levin]

    Datawatch Corporation (NASDAQ: DWCH) shares were also up, gaining 14 percent to $8.10 after the company reported a narrower-than-expected quarterly loss.

Top 10 Undervalued Stocks To Invest In 2018: Black Box Corporation(BBOX)

Advisors’ Opinion:

  • [By Monica Gerson]

    Black Box Corporation (NASDAQ: BBOX) is expected to post its quarterly earnings at $0.26 per share on revenue of $218.41 million.

    Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

Top 10 Undervalued Stocks To Invest In 2018: Deer Valley Corporation (DVLY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Deer Valley (OTCPK:DVLY)

    This company manufactures factory-made homes which are marketed to 14 states in the US. After the financial crisis it has been able to pick up its operations and continue to create sustainable free cash flow and increasing profits. It might be that another similar shock to housing is not necessarily around the corner and therefore they could sustain this in the foreseeable future.

Top 10 Undervalued Stocks To Invest In 2018: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By Alex McGuire]

    Meanwhile, the 61 healthcare stocks in the S&P 500 – such as AbbVie Inc. (NYSE: ABBV) and Humana Inc. (NYSE: HUM) – offer an average yield of 1.75%.

  • [By Lisa Levin]

    Humana Inc (NYSE: HUM) delivered better than expected results for the third quarter. However, the company’s adjusted EPS forecast came in below the estimates.

  • [By Lee Jackson]

    Health care giant Humana Inc. (NYSE: HUM) had a director and the chief operating officer of the company selling stock last week. The director sold 27,000 shares at prices between $204.51 and $206.43. The total for the sale was $7 million. COO Jim Murray sold 122,571 shares at prices that ranged from $204.231 to $206. The total for his trade was posted at $25 million. Shares closed on Friday at $207.28. The 52-week range is $150 to $217.80, and the consensus price target is $223.21.

  • [By ]

    The deal still needs approval from regulators, but there are fewer potential objections than the attempted tie-up between Aetna and Humana (NYSE: HUM), two insurers. While CVS does manage some drug-benefits plans for employers and insurers through its PBM, the merger wouldn’t create less competition in one particular segment of the industry like the insurance market.

  • [By Ben Levisohn]

    The Wall Street Journal reported that government regulators are pushing back against Anthem’s (ANTM) purchase of Cigna (CI). California, however, seems to have few issues with the proposed combination of Aetna (AET) andHumana (HUM). Leerink’s Ana Gupte explains:

  • [By Ben Levisohn]

    Humana (HUM) soared to the top of the S&P 500 today after the Republican Congress put forward a plan to repeal and replace the Affordable Care Act.

    S. MARTIN/AFP/Getty Images

    Humana gained 2.4% to $217.76 today, while the S&P 500 dropped 0.3% to 2,368.38.

    Why was Humana the best performing stock in the S&P 500? Beats the heck out of me, since what a final plan will look like is still up in the air. Strategas Research Partners’ Daniel Clifton and team explain:

    Handwringing about what this bill achieves or not is at a fevered pitch this morning. Our guess is that the final legislation will look quite different than the original draft as was the case eight years ago when the Democrats released their ACA draft and spent the next 12 months fighting over the details. There is a wide chasm of views between conservative House Republicans and moderate Republican Senators. Support is going to be needed from each group to win passage. The most logical complaint is that this is one entitlement program being replaced with another. But how ironic would it be if the Tea Party, which came to fruition in response to the ACA, actually becomes the barrier to reforming the law. Supporters of the ACA and investors in healthcare service companies will be focused on the number of covered lives. There is no doubt that a reformed Medicaid system (to get costs down) and less generous tax credits will lead to fewer covered lives. How much of a difference will be open to interpretation as policymakers await the CBO score.

    Humana’s market capitalization rose to $32.5 billion today from $31.8 billion yesterday. It reported net income of $614 million on sales of $54.4 billion in 2016.

Top Safest Stocks To Buy Right Now

Argument

McDonald’s will benefit from these planned deals by smoothing out earnings performance in its operations in these regions and more efficiently place management’s focus on broader-scale expansion and brand initiatives. The company’s liquidity position isn’t materially impacted by these intended transactions and any earnings dip will likely be temporary and counterbalanced by reducing quarter-to-quarter volatility in performance. Accordingly, from the perspective of investors, these deals aren’t likely to move the needle too significantly.

Top Safest Stocks To Buy Right Now: Celanese Corporation(CE)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Albemarle Corporation (NYSE: ALB): Free Stock Analysis Report
     
    Celanese Corporation (NYSE: CE): Free Stock Analysis Report
     
    Kronos Worldwide Inc (NYSE: KRO): Free Stock Analysis Report
     
    Koppers Holdings Inc. (NYSE: KOP): Free Stock Analysis Report
     
    Chemours Company (The) (CC): Free Stock Analysis Report
     
    Kraton Corporation (NYSE: KRA): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

  • [By Ben Levisohn]

    Time To Favor Optionality: Most macro data are similar to, or better than, when the merger was announced. As a result, the same returns have been obtainable, with significantly less stress, simply through owning 3M (MMM) or a basket of chemical companies that approximate the Dow-DuPont portfolio. Relative to the chemical sector, performance has been average, leverage appears reasonable but near-term FCF less-than compelling partly due to new capacity ramping. With the merger likely to close in the near-term (90% chance, in our view), we believe Dow-DuPont will have an opportunity to show how scale creates optionality. The overhaul at Celanese (CE) over the past few years shows the way.

Top Safest Stocks To Buy Right Now: Natus Medical Incorporated(BABY)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Monday, our Elite Opportunity Pronewsletter suggested going long on small cap healthcare products and services stock Natus Medical (NASDAQ: BABY):

Top Safest Stocks To Buy Right Now: AmTrust Financial Services, Inc.(AFSI)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, financial shares fell 0.32 percent. Meanwhile, top losers in the sector included Oak Valley Bancorp (NASDAQ: OVLY), down 7 percent, and AmTrust Financial Services Inc (NASDAQ: AFSI) down 5 percent.

  • [By Lisa Levin]

    Shares of AmTrust Financial Services Inc (NASDAQ: AFSI) were down around 18 percent to $22.79 after the company posted downbeat Q4 earnings.

    Shutterstock Inc (NYSE: SSTK) was down, falling around 19 percent to $42.04 after the company reported downbeat Q4 results and issued a weak outlook.

  • [By Paul Ausick]

    AmTrust Financial Services Inc. (NASDAQ: AFSI) dropped more than 18% Monday, to post a new 52-week low of $22.58 after closing at $27.66 on Friday. The stock’s 52-week high is $28.48. Volume was more than 10 times the daily average of around 670,000 shares. The company missed profit estimates this morning.

  • [By Paul Ausick]

    AmTrust Financial Services Inc. (NASDAQ: AFSI) dropped about 28% Tuesday to post a new 52-week low of $13.51 after closing Monday at $18.87. The stock’s 52-week high is $28.48. Volume of about 19 million shares was about 9 times the daily average of around 2.1 million. A whistleblower report has resulted in an SEC probe into the company’s accounting practices.

  • [By Dan Caplinger]

    The stock market kept performing well on Monday, and the Dow Jones Industrials posted its 12th straight all-time record high. Market sentiment was sunny following the release of Warren Buffett’s annual shareholder letter over the weekend, and the Oracle of Omaha made positive comments about the sustainability of the current bull market, which was able to overcome early declines in the major market benchmarks. However, some stocks didn’t fare as well as the overall market, and Tesla (NASDAQ:TSLA), AmTrust Financial Services (NASDAQ:AFSI), and Horizon Pharma (NASDAQ:HZNP) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli

Top Safest Stocks To Buy Right Now: Hatteras Financial Corp(HTS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Hatteras Financial (HTS) has jumped 9.4% to $15.60 after agreeing to be purchased byAnnaly Capital Management (NLY) for $1.5 billion.Annaly Capital Management has dropped 1.1% to $$10.30.

Top Safest Stocks To Buy Right Now: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By Alex McGuire]

    Meanwhile, the 61 healthcare stocks in the S&P 500 – such as AbbVie Inc. (NYSE: ABBV) and Humana Inc. (NYSE: HUM) – offer an average yield of 1.75%.

  • [By Ben Levisohn]

    How good were UnitedHealth Group’s (UNH) earnings today? So good its stock has jumped the most in more than six years–and lifted competitors like Humana (HUM), Cigna (CI), Aetna (AET), and Anthem (ANTM) as well. Leerink’s Ana Gupte explains why the market is in love with UnitedHealth’s earnings:

  • [By Lee Jackson]

    Health care giant Humana Inc. (NYSE: HUM) had a director and the chief operating officer of the company selling stock last week. The director sold 27,000 shares at prices between $204.51 and $206.43. The total for the sale was $7 million. COO Jim Murray sold 122,571 shares at prices that ranged from $204.231 to $206. The total for his trade was posted at $25 million. Shares closed on Friday at $207.28. The 52-week range is $150 to $217.80, and the consensus price target is $223.21.

  • [By Craig Jones]

    On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about unusually high options activity in Humana Inc (NYSE: HUM).

    He said options traders were buying aggressively the January 250 calls. Around 3,200 contracts were bought in the first half of the trading session Monday and they paid $5.60 for them. The trade breaks even at $255.60 or around 5 percent higher from the current stock price.

  • [By Ben Levisohn]

    Humana (HUM) soared to the top of the S&P 500 today after the Republican Congress put forward a plan to repeal and replace the Affordable Care Act.

    S. MARTIN/AFP/Getty Images

    Humana gained 2.4% to $217.76 today, while the S&P 500 dropped 0.3% to 2,368.38.

    Why was Humana the best performing stock in the S&P 500? Beats the heck out of me, since what a final plan will look like is still up in the air. Strategas Research Partners’ Daniel Clifton and team explain:

    Handwringing about what this bill achieves or not is at a fevered pitch this morning. Our guess is that the final legislation will look quite different than the original draft as was the case eight years ago when the Democrats released their ACA draft and spent the next 12 months fighting over the details. There is a wide chasm of views between conservative House Republicans and moderate Republican Senators. Support is going to be needed from each group to win passage. The most logical complaint is that this is one entitlement program being replaced with another. But how ironic would it be if the Tea Party, which came to fruition in response to the ACA, actually becomes the barrier to reforming the law. Supporters of the ACA and investors in healthcare service companies will be focused on the number of covered lives. There is no doubt that a reformed Medicaid system (to get costs down) and less generous tax credits will lead to fewer covered lives. How much of a difference will be open to interpretation as policymakers await the CBO score.

    Humana’s market capitalization rose to $32.5 billion today from $31.8 billion yesterday. It reported net income of $614 million on sales of $54.4 billion in 2016.

Top Safest Stocks To Buy Right Now: SodaStream International Ltd.(SODA)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q4 2016 earnings report for Israel based small cap home beverage carbonation stockSodastream International Ltd (NASDAQ: SODA) is scheduled for before the market opens onWednesday (February 15). However, theIsrael connection along with changing consumer tastes havesent sharesfrom fizzy to being flat. On the other hand,Sodastream International climbed 16.22% after releasing third quarter earnings that easily topped Wall Street expectations after making efforts to revamp its image.

  • [By Peter Graham]

    Israel based small cap home beverage carbonation stockSodastream International Ltd (NASDAQ: SODA) reported Q1 2017 earnings before the market opened this morning. Revenue increased 14.3% to $115.3 million driven by growth in each of the Company’s four geographic regions, partially offset by a negative foreign currency exchange impact mainly due to the weakening of the Euro/U.S. Dollar exchange rate compared to the same period in 2016. Net income increased 141.8% to $14.7 million.

  • [By Peter Graham]

    Israel based small cap home beverage carbonation stockSodastream International Ltd (NASDAQ: SODA) reportedQ2 2017 earnings before the market opened on Wednesday. Revenue increased 9.6% to $130.6 millionwith theincrease driven by growth in most of the Company’s geographic regions -mainly Western Europe, partially offset by a negative foreign currency exchange impact mainly due to the weakening of the Euro/U.S. Dollar exchange rate compared to the same period in 2016. Net income increased approximately 84% to $14.4 million. As of June 30, 2017, the Company had cash and bank deposits totaling $108.5 million compared to $57.3 millionas ofDecember 31, 2016. The CEO commented:

  • [By Jeremy Bowman]

    SodaStream International(NASDAQ:SODA) blew the market away in 2016 as shares of the DIY soda-maker popped 142%, beating all but two stocks in the S&P 500.

Best Warren Buffett Stocks For 2018

March has brought madness to airline stocks, including United Continental Holdings (UAL), Delta Air Lines (DAL), and American Airlines (AAL). But the recent pullbacks aren’t a buying opportunity, say Imperial Michael Derchin and Adam Hackel.

Agence France-Presse/Getty Images

I recommended United Continental on Nov. 19, the week that Warren Buffett’s Berkshire Hathaway (BRK.B) placed a bet on the group. And while the recommendation had been looking good until this week, when United Continental said it would be expanding capacity. That caused its shares to drop shares to drop 6.9% this week–and my bet to become a loser with a 1.4% drop since I recommended it.

So should you hang on to your airline shares? Not to hear Imperial’s Derchin and Hackel tell it:

While the airline stocks have pulled back recently, coming off a choppy 1Q17, we have In-Line ratings on the Big 3 (American Airlines [AAL], Delta Air Lines [DAL] and United Continental [UAL]), as well as on Alaska Air Group (ALK)…

Best Warren Buffett Stocks For 2018: Halyard Health, Inc.(HYH)

Advisors’ Opinion:

  • [By Nelson Hem]

    Medical products maker Halyard Health Inc (NYSE: HYH) stumbled after its spinoff from paper products giant Kimberly Clark Corp (NYSE: KMB), according to “Halyard Health Shares Look Poised to Double” by David Englander. See why Barron’s thinks its shares could double as this Georgia-based company pursues acquisitions and expands its product lineup.

  • [By Nelson Hem]

    See what Barron’s feels are the prospects for Ingersoll-Rand PLC (NYSE: IR) despite the woes in energy, Michael Kors Holdings Ltd (NYSE: KORS) with its new products and international expansion, the Valvoline spinoff from Ashland Inc (NYSE: ASH), as well as Halyard Health Inc (NYSE: HYH) as it pursues acquisitions and expands its product lineup.

Best Warren Buffett Stocks For 2018: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Clinton 15 stock basket (DBUSCLNT): UnitedHealth Group (UNH), Humana (HUM), McKesson (MCK), Aecom (ACM), Quanta Services (PWR), ExxonMobil (XOM), Alcoa (AA), NextEra Energy (NEE), Cree (CREE), First Solar (FSLR), Facebook (FB), Netflix (NFLX), Prudential Financial (PRU), Citigroup (C), Union Pacific (UNP).

  • [By ]

    The deal still needs approval from regulators, but there are fewer potential objections than the attempted tie-up between Aetna and Humana (NYSE: HUM), two insurers. While CVS does manage some drug-benefits plans for employers and insurers through its PBM, the merger wouldn’t create less competition in one particular segment of the industry like the insurance market.

  • [By Craig Jones]

    On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about unusually high options activity in Humana Inc (NYSE: HUM).

    He said options traders were buying aggressively the January 250 calls. Around 3,200 contracts were bought in the first half of the trading session Monday and they paid $5.60 for them. The trade breaks even at $255.60 or around 5 percent higher from the current stock price.

  • [By Lisa Levin]

    Humana Inc (NYSE: HUM) delivered better than expected results for the third quarter. However, the company’s adjusted EPS forecast came in below the estimates.

  • [By Ben Levisohn]

    How good were UnitedHealth Group’s (UNH) earnings today? So good its stock has jumped the most in more than six years–and lifted competitors like Humana (HUM), Cigna (CI), Aetna (AET), and Anthem (ANTM) as well. Leerink’s Ana Gupte explains why the market is in love with UnitedHealth’s earnings:

  • [By Ben Levisohn]

    Humana (HUM) soared to the top of the S&P 500 today after the Republican Congress put forward a plan to repeal and replace the Affordable Care Act.

    S. MARTIN/AFP/Getty Images

    Humana gained 2.4% to $217.76 today, while the S&P 500 dropped 0.3% to 2,368.38.

    Why was Humana the best performing stock in the S&P 500? Beats the heck out of me, since what a final plan will look like is still up in the air. Strategas Research Partners’ Daniel Clifton and team explain:

    Handwringing about what this bill achieves or not is at a fevered pitch this morning. Our guess is that the final legislation will look quite different than the original draft as was the case eight years ago when the Democrats released their ACA draft and spent the next 12 months fighting over the details. There is a wide chasm of views between conservative House Republicans and moderate Republican Senators. Support is going to be needed from each group to win passage. The most logical complaint is that this is one entitlement program being replaced with another. But how ironic would it be if the Tea Party, which came to fruition in response to the ACA, actually becomes the barrier to reforming the law. Supporters of the ACA and investors in healthcare service companies will be focused on the number of covered lives. There is no doubt that a reformed Medicaid system (to get costs down) and less generous tax credits will lead to fewer covered lives. How much of a difference will be open to interpretation as policymakers await the CBO score.

    Humana’s market capitalization rose to $32.5 billion today from $31.8 billion yesterday. It reported net income of $614 million on sales of $54.4 billion in 2016.

Best Warren Buffett Stocks For 2018: Intrepid Potash, Inc(IPI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Intrepid Potash, Inc. (NYSE: IPI) and L.B. Foster Co (NASDAQ: FSTR).

  • [By Lisa Levin]

    Wednesday afternoon, basic materials shares gained by 1.74 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), and L.B. Foster Co (NASDAQ: FSTR).

  • [By Lisa Levin]

    Monday afternoon, the basic materials shares surged 0.57 percent. Meanwhile, top gainers in the sector included CF Industries Holdings, Inc. (NYSE: CF), up 7 percent, and Intrepid Potash, Inc. (NYSE: IPI), up 7 percent.

what to invest in

All things considered, it’s pretty safe to say the market was underestimating Exxon Mobil Corporation (NYSE:XOM). Or, perhaps it would be more accurate to say investors overestimated the adverse impact hurricanes Harvey and Irma would have on the company’s operations. XOM stock edged even higher in the wake of Friday morning’s third quarter report, extending a rally that’s been building since early September.

Source: Mike Mozart via Flickr (Modified)

Is this the move that will get — and keep — the XOM stock price over the hump? Maybe. In some regards it’s already over the hump, though we’ve seen this before, but to no avail. The good news is that the “what” that will keep Exxon Mobil shares on the bullish side of the fence is on the verge of happening.

what to invest in: RXI Pharmaceuticals Corporation(RXII)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, our Under the Radar Moversnewsletter suggested small cap clinical-stage biotech RXi Pharmaceuticals Corp (NASDAQ: RXII) as a long/bullish trade for our short-term portfolio:

what to invest in: Level 3 Communications, Inc.(LVLT)

Advisors’ Opinion:

  • [By Ben Levisohn]

    A rumored merger with CenturyLink (CTL) sent Level 3 Communications (LVLT) soaring to the top of the S&P 500 today.

    Pixabay

    Shares of Level 3 Communications climbed 11% to $51.87 today, even as the S&P 500 declined 0.3% to 2,133.04. CenturyLink didn’t perform too badly, either: It gained 9.7% to $31.

  • [By Benzinga News Desk]

    On Thursday afternoon, Wall Street Journal reported that CenturyLink (NYSE: CTL) was in advanced talks to merge with Level 3 Communications (NYSE: LVLT). Back on July 13, Benzinga Pro reported Level 3 was reviewing strategic alternatives.

  • [By Ben Levisohn]

    After opening up 0.6% this morning, Level Three Communications (LVLT) jumped as much as 5.9% on reports that it was considering ways to increase shareholder value (nudge nudge, wink wink, know what I mean?). Citigroup’s Michael Rollins and Neth Wiedemann offer their take:

    Online news source Benzinga recently tweeted that an industry source has told them Level 3 is “reviewing strategic alternatives to maximize holder value, including outright sale or large buyback”. Level 3 shares are up ~4% today after a ~3% move yesterday and shares are up ~10% over the past week. The company has not responded to the news, nor can we substantiate the speculation.

    Level 3 remains our top-pick within our coverage group given its growth, financial flexibility, valuation, and strategic optionality.Level 3 currently trades around ~10x our 2016 OIBDA estimate and ~11x our 2016 discretionary FCF estimate, which we believe is too cheap given its growth profile and deep strategic asset-mix of metro and long-haul fiber.

    We believe that Level 3′s extensive enterprise presence could be attractive for a cable player looking to move up-market and accelerate its investment from thesmall- to medium-sized businesses segment into the enterprise market. We also believe that Zayo Group Holdings (ZAYO) may be an attractive acquisition target for a cable company looking to accelerate an enterprise strategy. We also would not dismiss the possibility that Level 3 and Zayo could consider a merger scenario to become a larger competitor for the enterprise market against the incumbents AT&T (T) and Verizon Communications (VZ).

    Shares of Level 3 have gained 3.7% to $56.39 at 1:20 p.m. today, while Zayo Group Holdings has risen 1% to $28.78, AT&T has advanced 0.5% to $42.61, and Verizon Communications is up 0.7% to $55.87.

what to invest in: Royal Bank Scotland plc (The)(RBS)

Advisors’ Opinion:

  • [By Jonathan Morgan]

    Adidas AG slid 2.9 percent after lowering its profit forecast for 2013. Direct Line Insurance Group Plc lost 2.5 percent as Royal Bank of Scotland Group Plc (RBS) sold a 630 million-pound ($1 billion) stake in the U.K.s biggest car insurer.

  • [By Paul R. La Monica]

    European banks worse off than 2008? Lamensdorf is concerned about the exposure to bad loans (especially energy company debt) held by big banks such as Royal Bank of Scotland (RBS), Credit Suisse (CS) and Deutsche Bank (DB). He’s shorting all three.

what to invest in: The Bon-Ton Stores, Inc.(BONT)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)reported fiscalQ1 earnings before the market opened this morning with total salesdown 9.3% to $536.1 million and comparable store sales down 8.8%. Theearnings release noted:

  • [By Peter Graham]

    Small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT) reported Q2 2017 earnings before the market opened on Thursday while earnings guidance for the full year fiscal 2017 was reaffirmed. Total sales decreased 7.0% to $504.4 million as comparable store sales decreased 6.1% versus the prior year period. However,double-digit sales growth continued in the omnichannel, which reflects sales via the Company’s website, mobile site, and its Let Us Find It customer service program, as the Company leveraged its West Jefferson facility and store-fulfillment network. The net loss was $33.2 million versus a net loss of $38.7 million.The CEO commented:

  • [By Peter Graham]

    The Q3 2016 earnings report for small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)is scheduled for before the market opens on Thursday (November 17th) as traditional department stores continue to struggle to figure out how to attract costumers into their stores as online giants increasingly become thedominant retail players.

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap department store stock The Bon-Ton Stores, Inc (NASDAQ: BONT)is scheduled for before the market opens on Tuesday (March 14th). In January, The Bon-Ton Stores announced that its comparable store sales for the nine-week holiday period ended December 31, 2016 had decreased 3.1% -in line with guidance. The CEO commented:

what to invest in: Alexion Pharmaceuticals, Inc.(ALXN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) posted a new 52-week low of $102.47 on Tuesday, down more than 11% compared with Monday’s closing price of $115.42. The stock’s 52-week high is $157.02. Volume totaled more than 16 million shares, nearly 6 times the daily average of about 3 million. The company announced several executive changes this morning.

  • [By Ben Levisohn]

    Alexion Pharmaceuticals (ALXN) soared to the top of the S&P 500 today after its audit committee found no need to restate the company’s financials.

    Agence France-Presse/Getty Images

    Alexion Pharmaceuticalsgained 9.5% to $139.18 today, while the S&P 500 dipped 0.1% to 2,269.00.

    Morgan Stanley’sMatthew Harrison and team argue that the audit committees report is “lifting a cloud” over Alexion, but they still have their concerns:

    Without significant fireworks mgt. has filed the 10-Q lifting a cloud around the details on the potential wrong doing and its impact. While the “pull-in” sales had less than a 1% impact and do not appear pervasive in use as evidenced by the limited amount outside of 4Q15, we do wonder how the increased scrutiny will impact the selling organization and the potential increased conservatism among personnel going forward. We look forward to 2017 guidance and updates to MG filing and 1210 enrollment at the 4Q16 call.

    Alexion’s market capitalization rose to $31.2 billion today from $28.5 billion yesterday. It reported net income of $144 million on sales of $2.5 billion in 2015.

  • [By Johanna Bennett]

    Alexion Pharmaceuticals (ALXN), a drug maker focused on rare diseases, ended Thursday at the top of the list of the best performing stocks in the S&P 500 index.

    The shares climbed almost 3.3%, or $3.78, to close at $118.35, compared to the S&P 500, which fell almost 16 points, or 0.7% to end at 2,328.95.

    Its been a rough two years for Alexion. Since mid-2015, when the stock traded above $200, shares have tumbled on worries about the durability of its main drug Soliris, political furor over high drug prices, and the abrupt departure of two top executives amid an investigation into sales practices.

    The shares are down more than 3% since the start of 2017.

    Solaris sales will be a focus next week when Alexion reports first quarter financial results. Earlier today, Barclays reiterated an overweight rating on the stock and a $115 price target, but raised its 2018 and 2019 earnings estimates, arguing that rivals are unlikely to significantly challenge either Solaris or the experimental drug ALXN1210.

    …we are increasingly comfortable with the Soliris outlook and now forecast 2021E sales at $4.8B vs. our previous $4.6B, which is +5% ahead of consensus. Weve raised 2017 and 2018 adjusted EPS estimates by $0.05 and $0.10 respectively. Our 5-year revenue CAGR increases by +70 bps to 14.7% while EPS growth has improved by +100 bps to 20.0%, near the top of the peer group.

    Barrons weighed in on Alexion in February, which has been bandied about as a takeout candidate. We have argues

    Earlier this week, Credit Suisse analysts listed Alexion as one of three biotech stocks that will steal the spotlight during earnings season.

  • [By David Sterman]

    Growth-oriented investors should also check out Alexion Pharmaceuticals (Nasdaq: ALXN(link is external)), which falls through the cracks between the massive well-established biotechs, and the small-cap biotechs that are still pre-revenue.

    Alexion targets rare and severe diseases, and has built a broad platform of drugs to treat them. Sales growth has never been less than 37% at any point in the past eight years, and 20% to 25% growth appears locked in over coming years as well. Analysts at UBS, who see 30% upside to their $202 price target, believe that a healthy drug pipeline provides multiple catalysts this year in the form of clinical trial updates. They suggest that shares would be worth $230 in a buyout scenario. 

what to invest in: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Humana Inc (NYSE: HUM) delivered better than expected results for the third quarter. However, the company’s adjusted EPS forecast came in below the estimates.

  • [By Alex McGuire]

    Meanwhile, the 61 healthcare stocks in the S&P 500 – such as AbbVie Inc. (NYSE: ABBV) and Humana Inc. (NYSE: HUM) – offer an average yield of 1.75%.

  • [By ]

    The deal still needs approval from regulators, but there are fewer potential objections than the attempted tie-up between Aetna and Humana (NYSE: HUM), two insurers. While CVS does manage some drug-benefits plans for employers and insurers through its PBM, the merger wouldn’t create less competition in one particular segment of the industry like the insurance market.

Top 10 Undervalued Stocks To Buy For 2018

Comfort Systems USA, Inc (“FIX”, or the “company”) provides mechanical contracting services, primarily HVAC, plumbing, as well as off-site construction, electrical, monitoring and fire protection. The company has performed well over the last several years, with good revenue growth and margin expansion. FIX and its peers have spoken about increased demand for their products and services. However, FIX is currently undervalued relative to its peer group. There is reason to believe that FIX deserves a higher valuation and we will explore several of those areas.

Per the FIX’s 2015 10-K, the company has 35 operating units in 81 cities and 89 locations throughout the U.S. For full-year 2015, revenue was derived from four service activities, including: HVAC (77%); Plumbing (14%); Building Automation Controls (5%); and Other (4%). Approximately 44% of revenue was derived from newly constructed facilities and 56% was from renovation, expansion or maintenance. The service activities have remained steady as outlined in the chart below.

Top 10 Undervalued Stocks To Buy For 2018: Caseys General Stores, Inc.(CASY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Casey's General Stores Inc (NASDAQ: CASY) reported weaker-than-expected earnings for its second quarter.

    Casey's reported Q2 earnings of $1.28 per share on revenue of $2.154 billion. Analysts were expecting earnings of $1.40 per share on sales of $2.18 billion.

  • [By Chad Fraser]

    One chain that continues to match up well with the above criteria is Casey’s General Stores (NasdaqGS: CASY). We last highlighted the company’s strong prospects in a December 12 Investing Daily article. Since then, the stock has risen nearly 40%.

  • [By Taylor Cox]

    Notable Earnings

    Casey’s General Stores, Inc (NASDAQ: CASY) Q2 after hours

    Secondary Offering Lockup Expirations

    Athenex, Inc (NASDAQ: ATNX)

    IPO Quiet Period Expirations

Top 10 Undervalued Stocks To Buy For 2018: Mitel Networks Corporation(MITL)

Advisors’ Opinion:

  • [By Lisa Levin]

    ShoreTel Inc (NASDAQ: SHOR) shares shot up 28 percent to $7.47. Mitel Networks Corp (NASDAQ: MITL) announced plans to acquire Shortel for $7.50 per share in cash.

Top 10 Undervalued Stocks To Buy For 2018: Hudson Technologies, Inc.(HDSN)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Finally, Cramer said Hudson Technologies (HDSN) was a great stock to own in 2016, when shares soared 170%, but this year, he cannot recommend this high-flying refrigeration company.

  • [By Lisa Levin]

    Hudson Technologies, Inc. (NASDAQ: HDSN) shares dropped 13 percent to $6.55 amid concerning guidance. The company said it is expecting Q3 EPS of $0.03-$0.05 versus an analyst consensus estimate of $0.10. Sales are expected to be around $25 million versus the analyst estimate of nearly $41 million.

Top 10 Undervalued Stocks To Buy For 2018: EPAM Systems, Inc.(EPAM)

Advisors’ Opinion:

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    Read on to see why they pickedAllstate(NYSE:ALL),EPAM Systems(NYSE:EPAM), andUniversal Display(NASDAQ:OLED).

    Image source: Getty Images.

Top 10 Undervalued Stocks To Buy For 2018: US Foods Holding Corp. (USFD)

Advisors’ Opinion:

  • [By Jayson Derrick]

    But Amazon’s ultimate end-goal would likely be turning stores into “centralized distribution centers for groceries” but “we err on the futuristic side given Bezos thinks big.”

    Company Commentary
    Kroger Co (NYSE: KR) may be best positioned to counter Amazon’s threat given its own data analytics capabilities. SYSCO Corporation (NYSE: SYY) and US Foods Holding Corp (NYSE: USFD) are likely safe as Amazon won’t move into the foodservice distribution space which is very different from serving individual customers.

    Related Links:

  • [By Ben Levisohn]

    Guggenheim’sJohn Heinbockel and team argue that a “purging of space is necessary” in retail, and recommend hiding in “industry leaders who canprofitably gain share and are not especially expensive,” like Michaels (MIK), Tractor Supply (TSCO), Restoration Hardware (RH), Kroger (KR),and US Foods Holding (USFD). They explain:

Top 10 Undervalued Stocks To Buy For 2018: Consolidated Communications Holdings Inc.(CNSL)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, telecommunications services shares fell by 0.96 percent. Meanwhile, top losers in the sector included Consolidated Communications Holdings Inc (NASDAQ: CNSL), down 7 percent, and Internet Gold Golden Lines Ltd (NASDAQ: IGLD), down 6 percent.

  • [By Lisa Levin]

    Wednesday afternoon, the telecommunications services sector proved to be a source of strength for the market. Leading the sector was strength from Consolidated Communications Holdings Inc (NASDAQ: CNSL) and Telecom Argentina SA (ADR) (NYSE: TEO).

Top 10 Undervalued Stocks To Buy For 2018: CIENA Corporation(CIEN)

Advisors’ Opinion:

  • [By Billy Duberstein]

    The reasons for the price drop could be a number of things, including increased competition, notably from Ciena(NYSE: CIEN). This was noted by CEO Thomas Fallon who, in the recent conference call, noted competitors may be trying to “buy” market share:

  • [By Trey Thoelcke]

    Ciena Corp. (NYSE: CIEN) will report its most recent quarterly results Thursday morning. The consensus estimates call for EPS of $0.49 and $726.84 million in revenue. Shares closed at $23.87 on Friday, in a 52-week range of $18.94 to $27.98. The consensus price target is $30.77.

  • [By Dan Caplinger]

    Wednesday was a mixed day for the stock market, with the Dow Jones Industrials falling while the Nasdaq Composite posted modest gains. Parts of the market reacted differently to conflicting news items, which included both poor performance in the energy market and signs of promise for the economy more broadly. Despite the conflict among industry sectors, some stocks got hit particularly hard, and Rite Aid (NYSE:RAD), Ciena (NYSE:CIEN), and Express (NYSE:EXPR) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Lee Jackson]

    Ciena Corp. (NYSE: CIEN) is another tech company that saw insider selling last week. The president and CEO of the optical giant, Gary Smith, sold a reported 114,318 shares at $24.67 per share. The total for the trade was set at a solid $2,820,225. Shares closed last Friday at $24.41, in a 52-week range of $15.62 to $25.19. The consensus price target is $28.36.

Top 10 Undervalued Stocks To Buy For 2018: Controladora Vuela Compania de Aviacion, S.A.B. de C.V.(VLRS)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    In addition to Southwest, Alaska Air, and JetBlue, Mexican ultra-low cost carriers (ULCCs)Volaris (NYSE:VLRS) and VivaAerobus requested numerous slots in Mexico City. However, the DOT showed a strong preference for the U.S. carriers’ requests. In fact, Southwest Airlines, Alaska Air, and JetBlue Airways each received all of the slots they wanted.

Top 10 Undervalued Stocks To Buy For 2018: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The Wall Street Journal reported that government regulators are pushing back against Anthem’s (ANTM) purchase of Cigna (CI). California, however, seems to have few issues with the proposed combination of Aetna (AET) andHumana (HUM). Leerink’s Ana Gupte explains:

  • [By David Zeiler]

    Aetna is the focus of the senators’ wrath, but four of the five largest U.S. health insurers have a stake in this fight:

    No. 3 Aetna is attempting to acquire No. 5 Humana Inc. (NYSE: HUM); andNo. 2 Anthem Inc. (NYSE: ANTM) is seeking to acquire No. 4 Cigna Corp. (NYSE: CI).

    Related: Why the Cost of Obamacare Plans Will Continue to Skyrocket

  • [By Lee Jackson]

    Health care giant Humana Inc. (NYSE: HUM) had a director and the chief operating officer of the company selling stock last week. The director sold 27,000 shares at prices between $204.51 and $206.43. The total for the sale was $7 million. COO Jim Murray sold 122,571 shares at prices that ranged from $204.231 to $206. The total for his trade was posted at $25 million. Shares closed on Friday at $207.28. The 52-week range is $150 to $217.80, and the consensus price target is $223.21.

  • [By Craig Jones]

    On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about unusually high options activity in Humana Inc (NYSE: HUM).

    He said options traders were buying aggressively the January 250 calls. Around 3,200 contracts were bought in the first half of the trading session Monday and they paid $5.60 for them. The trade breaks even at $255.60 or around 5 percent higher from the current stock price.

Top 10 Undervalued Stocks To Buy For 2018: Dillard's, Inc.(DDS)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap department store stock Dillard’s, Inc (NYSE: DDS), whos potential peers includemid caps Macy’s, Inc (NYSE: M) and Nordstrom, Inc (NYSE: JWN) and small cap J C Penney Company Inc (NYSE: JCP), is the most shorted stock on the NYSE with short interest of 60.80% according to Highshortnterest.com.

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores spiking twice in 2013 and has been falling off for a longer period of time thanlarge cap Macy’s, Inc (NYSE: M) andsmall capDillard’s, Inc (NYSE: DDS)whilesmall cap J C Penney Company Inc (NYSE: JCP) was crushed much earlier:

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores spiking twice in 2013 and then, along withlarge cap Macy’s, Inc (NYSE: M) and mid capDillard’s, Inc (NYSE: DDS), having large declines that may or may not have leveled offwhilesmall cap J C Penney Company Inc (NYSE: JCP) has lost most of its value:

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores having two spikes while it along withlarge cap Macy’s, Inc (NYSE: M) and mid capDillard’s, Inc (NYSE: DDS) have posted large declines last year that may or may not have leveled off andsmall cap J C Penney Company Inc (NYSE: JCP) has at least stopped the bleeding:

  • [By Peter Graham]

    A long term performance chart shows shares of The Bon-Ton Stores spiking twice in 2013 and largely falling off since then while large cap Macy’s, Inc (NYSE: M) andsmall capDillard’s, Inc (NYSE: DDS)began falling off in 2015 andsmall cap J C Penney Company Inc (NYSE: JCP) was crushed much earlier:

3 Potential Takeover Targets After The CVS-Aetna Merger

News of the Senate vote on tax reform last week buried another headline, one that could be just as momentous in remaking an entire sector of the American economy.

Health insurer Aetna (NYSE: AET) has agreed to an acquisition by CVS Health (NYSE: CVS) in a $68 billion deal that could transform the healthcare industry. The addition of Aetna’s 22 million insurance customers will create one of the most vertically-integrated behemoths in the industry when added to CVS’s nation-wide pharmacy business, pharmaceutical benefits manager (PBM), and retail medical services.

The ability to insure, negotiate drug prices, and deliver health services and pharmaceuticals to customers could create a new standard in healthcare delivery.

This, combined with financial tailwinds from the potential tax reform package, could set off a wave of merger activity in 2018.

And I’ve found three leaders that could be prime investment targets.

How Could This $68 Billion Mega-Deal Reshape Healthcare?
At $68 billion in cash and stock, the deal is more than twice the size of the next largest M&A deal so far this year. More than the size of the tie-up, the deal could have major significance for the future of healthcare.

After the deal, the combined company would have an unequaled advantage in keeping customers, from diagnosis through drug delivery. The Aetna side of the business will insure customers and can guide them to using CVS services for medical services and pharmaceutical delivery. The PBM will now have even larger customer scale on which to negotiate prices from manufacturers.

The deal still needs approval from regulators, but there are fewer potential objections than the attempted tie-up between Aetna and Humana (NYSE: HUM), two insurers. While CVS does manage some drug-benefits plans for employers and insurers through its PBM, the merger wouldn’t create less competition in one particular segment of the industry like the insurance market.

That scale and control over the health delivery market could drive other companies to vertically integrate others as well.

Not only might the advantages of a CVS-Aetna combination drive other deals but the proposed tax plan in Congress could act as another impetus for a heavy 2018 M&A schedule. Companies could be looking at repatriating billions from overseas, money that will need to be deployed or returned to shareholders. Companies could also take advantage of higher earnings from a lower tax rate to make strategic acquisitions.

This confluence of tailwinds could set off a wave of healthcare mergers in the year to come.

Potential Targets In Healthcare Include PBMs And Pharma Suppliers
CVS is paying approximately $207 per share for Aetna in cash and stock, or 20.3 times the last four quarters’ earnings per share. That’s a 30% premium to where the shares were trading before rumors of the acquisition broke and signals the interest in the industry for consolidation.

Potential targets after the merger include PBMs, which have been weak this year on headline risks over drug pricing. They have come under fire as part of the problem but are also seen as essential for helping companies negotiate prices for their plans. The PBMs’ part in the health care chain is a valuable link and a critical piece for any company seeking vertical integration along the delivery system.

Express Scripts Holding (Nasdaq: ESRX) has already stated publicly that it would be open to an acquisition. The company is the largest PBM in the United States, with more than 1.4 billion adjusted claims processed annually as well as a strong home delivery pharmaceuticals service.

The three major PBMs, CVS, Express Scripts and UnitedHealth, control nearly 80% of all prescription volume in the United States. CVS is becoming a powerhouse and UnitedHealth would be a tough merger to swallow at $215 billion. That means any company trying to compete in the post-CVS-Aetna world may have no choice but to make an offer for Express Scripts.

Shares are down 1.8% this year and trade for 10 times earnings, less than half the industry average of 21 times trailing earnings. Earnings are expected to be higher by 9% over the next four quarters on a 1.3% increase in revenue.

Another key link in the health care delivery chain is retail pharmaceutical distributors. Pharmacies have been especially strong this year at pressuring suppliers on generic drug pricing, leading to broad losses on shares, but there is evidence that the largest of the discounting is behind us.

Cardinal Health (NYSE: CAH) is major wholesaler of pharmaceuticals and medical supplies, with operations including nearly everything but manufacturing. The company is the third-largest distributor and counts CVS as its largest customer, meaning it could potentially benefit from higher volume after the CVS-Aetna deal.

Shares are down 21% this year and trade for 11.6 times trailing earnings. The entire industry is down sharply this year and trades for an average 12.5 times trailing earnings. Earnings for Cardinal Health are expected 2.7% lower over the next four quarters, but may surprise higher if drug price discounting slows.

McKesson Corporation (NYSE: MCK) is the largest wholesale distributor of pharmaceuticals, counting CVS and Walmart as major customers. Along with rivals Cardinal Health and AmerisourceBergen, the three control 90% of the $300 billion retail pharmaceutical distribution market.

Just as with the potential for an Express Scripts acquisition, that industry market control means both McKesson and Cardinal Health could be valuable pieces to any company’s strategic plans for vertical M&A next year.

Shares of McKesson are up just 3.5% this year and trade for 12.6 times earnings. Profits are expected higher by 3.1% over the next four quarters to $12.57 per share on an increase of 2.9% in revenue.

Risks To Consider: Shares of healthcare companies could be more volatile than usual on changes to the Affordible Care Act and headline risk on drug pricing over the next few years.

Action To Take: Look into taking a position in these potential takeover targets as the healthcare industry rushes to build vertically-integrated giants to compete with in a post CVS-Aetna industry.

Editor’s Note: The average Social Security benefit is $1,236 per month. But this Social Security Insurance averages $3,628 per month. Two thousand bucks MORE. There’s no easier way to earn $40,653 a year on the side. And you can start tomorrow. Check it out here.

Best Bank Stocks To Own Right Now

Citigroup (C) topped expectations when it unveiled quarterly financial results today, as did PNC Financial Services Group (PNC) and U.S. Bancorp (USB). Yet Wall Street is punishing bank stocks today.

What gives?

A slew of big financial firms posted earnings today, on the heels of the strong results released yesterday by J.P. Morgan (JPM). Yet the Financial Select Sector SPDR ETF (XLF) fell 0.5% in recent market action. Wells Fargo (WFC) led the charge, falling 2.9% after the company said second quarter profit fell and revenue missed expectations as low interest rates continued to weigh on results.

As for Citigroup, while profit and revenue beat expectations, the banks top line fell 10%. And according to Morningstar analyst Jim Sinegal investors are disappointing that banks have yet to start firing on all cylinders.

There were no big negatives in the quarter, but investors have been looking for banks to fire on all cylinders for a number of years. They want good credit performance and good revenue performance and not much in the way of unusual expenseOn the revenue front, low interest rates are still an overhang.

Best Bank Stocks To Own Right Now: Cracker Barrel Old Country Store Inc.(CBRL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is projected to report its quarterly earnings at $1.80 per share on revenue of $705.65 million.

  • [By Peter Graham]

    Mid capSouthern chicken restaurant stock Cracker Barrel Old Country Store, Inc (NASDAQ: CBRL) reportedearnings for fiscal Q1 2018 (ended October 27, 2017) before the market opened with results topping Wall Street expectations. Total revenue rose 0.1%to $710.4 million as comparable store restaurant sales increased 0.2%, including a 2.0% increase in average check partially offset by a 1.8% decrease in store traffic. The average menu price increase for the quarter was approximately 2.2% whilecomparable store retail sales decreased 3.6% from the prior year quarter. The Company opened two new Holler & Dash Biscuit House locations during the quarter, bringing the store count to 651 combined Cracker Barrel Old Country Store and Holler & Dash Biscuit House locations at quarter-end. Net income was $46.380 million versus net income of $48.355 million. Earnings per diluted share were $1.92, compared to diluted EPS of $2.01 in the prior year first quarter with the Company estimating that hurricanes Harvey and Irma reduced first quarter diluted EPS by approximately $0.07.

  • [By Peter Graham]

    Mid capSouthern chicken restaurant stock Cracker Barrel Old Country Store, Inc (NASDAQ: CBRL) reported Q3 earnings before the market opened this morning.Total revenue was flat at $700.4 million as comparable store restaurant sales decreased 0.4% as a 2.1% decline in comparable store restaurant traffic was partially offset by a 1.7% increase in average check. The average menu price increase for the quarter was approximately 1.6% andcomparable store retail sales decreased 4.7% from the prior year quarter. Comparable store restaurant traffic, average check and comparable store restaurant sales and retail sales for the fiscal months of February, March, and April and the third quarter were as follows:

  • [By Shauna O’Brien]

    Cracker Barrel Old Country Store, Inc. (CBRL) shares dropped over 4% on Wednesday morning after the company reported lower fourth quarter earnings and a weak outlook for its first quarter.

    The Lebanon, TN-based company reported fourth quarter earnings of $34.3 million, or $1.43 per share, down slightly from $34.7 million, or $1.47 per share, a year ago. On average, analysts expected to see earnings of $1.35 per share.

    Total revenue fell to $646.1 million from $700.01 million last year. Analysts expected to see revenue of $668.68 million.

    Cracker Barrel President and CEO Sandra Cochran commented: “The fourth quarter of fiscal 2013 represents the seventh consecutive quarter of year-over-year improvement in comparable store traffic, restaurant sales, and retail sales. The financial results of the fourth quarter and full year reflect the effective execution of our strategic plan. As we begin our 2014 fiscal year, we are poised to capitalize on the achievements of fiscal 2013.”

    For FY2013, CBRL’s earnings rose 14% to $117.27 million, while EPS rose to $4.90 per share. On an adjusted basis, earnings were $4.97 per share, up 15% from the year prior. Total revenue for the year was $2.64 billion, up 3% from a year ago.

    Looking forward, the company expects to see first quarter earnings between $1.05 and $1.15 per share. This estimate would fall significantly below the average analyst estimate of $1.32 per share.

    For FY2014, the company expects EPS in the range of $5.60 to $5.80 and revenue between $2.7 billion and $2.75 billion. Analysts expect to see earnings of $5.69 per share and $2.74 billion in revenue.

    Cracker Barrel shares were down $4.70, or 4.39%, during Wednesday morning trading. The stock is up 59% YTD.

  • [By Monica Gerson]

    Analysts are expecting Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) to have earned $1.80 per share on revenue of $705.65 million in the latest quarter. Cracker Barrel shares gained 0.67 percent to $152.50 in after-hours trading.

Best Bank Stocks To Own Right Now: HubSpot, Inc.(HUBS)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Cramer was bearish on Ferrellgas Partners (FGP) , Realty Income (O) , Synergy Pharmaceuticals (SGYP) , Avis Budget Group (CAR) and HubSpot (HUBS) .

  • [By Danny Vena]

    There’s another area being driven by AI that may surprise you. The next time you text your bank, cellphone service provider, or retailer, the agent you’re dealing with might be a chatbot. This form of conversational AI is being more widely adopted to perform simple customer service tasks. According to research conducted by marketing technology vendor HubSpot, Inc. (NYSE:HUBS), of 1,426 respondents worldwide, 74% had used voice search in the prior month, and 63% of people using services based on AI technology didn’t even know it.

Best Bank Stocks To Own Right Now: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By CNBC]

    Tony Tribble, Invision/AP
    Forget about Bloomin’ Onions or boneless wings, for many consumers, the choice of where to dine often comes down to a different factor: which restaurant has the best booze.
    “Alcoholic beverages can be a key driver of traffic, differentiation, and loyalty,” said David Decker, president of Consumer Edge Insight. According to the firm, two factors that keep customers coming back are “selection” and “pricing.”
    Consumer Edge Insight recently surveyed restaurant customers to find out which casual-dining spots generated the most loyalty with their alcoholic beverages.
    Taking the top spot for “selection” was Buffalo Wild Wings (BWLD), with 29 percent of those surveyed saying they were “most likely to visit it most often due to its good selection of alcoholic beverages.”
    Applebee’s (DIN) took the second spot, with 24 percent, and Outback Steakhouse (BLMN) and T.G.I. Friday’s tied for third place with 22 percent each.
    Prices also keep customers coming back to Buffalo Wild Wings.

    When asked which casual-dining brand they were “most likely to visit most often due to its good prices of alcoholic beverages,” Buffalo Wild Wings came out on top with 30 percent. Chili’s (EAT) was No. 2 at 23 percent, and Ruby Tuesday (RT) was third with 22 percent.
    Buffalo Wild Wings has always made alcohol a part of its experience, even making it part of its tagline: “Wings.Beer.Sports.”
    The chain is the No. 1 account for more than 50 different beer brands and recently launched Game Changer, a new beer in a partnership with Redhook Brewery. Priced between cheaper domestic lagers and pricier craft beers, Game Changer became the fourth-most-popular draft beer at company-owned locations within two weeks of its release.
    “Among casual-dining restaurants, Buffalo Wild Wings is seeing the greatest positive effect in terms of building customer loyalty with its alcohol offerings,” Decker said. “There are many steps other restaurants can take to improve their alcoho

Best Bank Stocks To Own Right Now: Arrow Electronics, Inc.(ARW)

Advisors’ Opinion:

  • [By Brian Mathews]

    Arrow Electronics Inc. (NYSE: ARW) is one of the world’s largest distributors of electric components and computer products. During 2015, ARW struggled primarily due to unfavorable currency fluctuations. However, the company has been seasonal toward the end of the year, especially in Europe, and is expected to carry that positive momentum into the New Year. Arrow has packaged its core products and value-added services into a comprehensive solution that lowers the cost base over a product’s lifetime, yet adds higher client engagement. With a diversified product line and successful current strategy, Arrow is well positioned to grow to a target price of $65.

Best Bank Stocks To Own Right Now: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By Alex McGuire]

    Meanwhile, the 61 healthcare stocks in the S&P 500 – such as AbbVie Inc. (NYSE: ABBV) and Humana Inc. (NYSE: HUM) – offer an average yield of 1.75%.

  • [By Lee Jackson]

    Health care giant Humana Inc. (NYSE: HUM) had a director and the chief operating officer of the company selling stock last week. The director sold 27,000 shares at prices between $204.51 and $206.43. The total for the sale was $7 million. COO Jim Murray sold 122,571 shares at prices that ranged from $204.231 to $206. The total for his trade was posted at $25 million. Shares closed on Friday at $207.28. The 52-week range is $150 to $217.80, and the consensus price target is $223.21.

  • [By David Zeiler]

    Aetna is the focus of the senators’ wrath, but four of the five largest U.S. health insurers have a stake in this fight:

    No. 3 Aetna is attempting to acquire No. 5 Humana Inc. (NYSE: HUM); andNo. 2 Anthem Inc. (NYSE: ANTM) is seeking to acquire No. 4 Cigna Corp. (NYSE: CI).

    Related: Why the Cost of Obamacare Plans Will Continue to Skyrocket

  • [By Ben Levisohn]

    Humana (HUM) soared to the top of the S&P 500 today after the Republican Congress put forward a plan to repeal and replace the Affordable Care Act.

    S. MARTIN/AFP/Getty Images

    Humana gained 2.4% to $217.76 today, while the S&P 500 dropped 0.3% to 2,368.38.

    Why was Humana the best performing stock in the S&P 500? Beats the heck out of me, since what a final plan will look like is still up in the air. Strategas Research Partners’ Daniel Clifton and team explain:

    Handwringing about what this bill achieves or not is at a fevered pitch this morning. Our guess is that the final legislation will look quite different than the original draft as was the case eight years ago when the Democrats released their ACA draft and spent the next 12 months fighting over the details. There is a wide chasm of views between conservative House Republicans and moderate Republican Senators. Support is going to be needed from each group to win passage. The most logical complaint is that this is one entitlement program being replaced with another. But how ironic would it be if the Tea Party, which came to fruition in response to the ACA, actually becomes the barrier to reforming the law. Supporters of the ACA and investors in healthcare service companies will be focused on the number of covered lives. There is no doubt that a reformed Medicaid system (to get costs down) and less generous tax credits will lead to fewer covered lives. How much of a difference will be open to interpretation as policymakers await the CBO score.

    Humana’s market capitalization rose to $32.5 billion today from $31.8 billion yesterday. It reported net income of $614 million on sales of $54.4 billion in 2016.

  • [By Ben Levisohn]

    Clinton 15 stock basket (DBUSCLNT): UnitedHealth Group (UNH), Humana (HUM), McKesson (MCK), Aecom (ACM), Quanta Services (PWR), ExxonMobil (XOM), Alcoa (AA), NextEra Energy (NEE), Cree (CREE), First Solar (FSLR), Facebook (FB), Netflix (NFLX), Prudential Financial (PRU), Citigroup (C), Union Pacific (UNP).

  • [By Ben Levisohn]

    The Wall Street Journal reported that government regulators are pushing back against Anthem’s (ANTM) purchase of Cigna (CI). California, however, seems to have few issues with the proposed combination of Aetna (AET) andHumana (HUM). Leerink’s Ana Gupte explains:

Best Bank Stocks To Own Right Now: Vanguard Mega Cap Growth ETF (MGK)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    Three of Vanguard's mega-cap equity ETFs now sport annual expense ratios of 0.07 percent, down from 0.09 percent. Those ETFs are the Vanguard Mega Cap ETF (NYSE: MGC), Vanguard Mega Cap 300 Growth Index ETF (NYSE: MGK) and the Vanguard Mega Cap Value Index ETF (NYSE: MGV).

Best Value Stocks To Own Right Now

Saudi Aramco could be valued at $2 trillion, making the Saudi Aramco IPO worth a massive $100 billion. That will make it the biggest IPO ever once the company goes public.

But the media is overlooking one key aspect of the Aramco IPO and is instead only focusing on the deal’s size.

Even though Saudi Arabia is only selling a 5% stake in the company, it will still potentially raise $100 billion. That’s more than four times the size of the current record set by Alibaba Group Holding Ltd. (NYSE: BABA) and its $25 billion 2014 IPO.

Best Value Stocks To Own Right Now: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By David Zeiler]

    Aetna is the focus of the senators’ wrath, but four of the five largest U.S. health insurers have a stake in this fight:

    No. 3 Aetna is attempting to acquire No. 5 Humana Inc. (NYSE: HUM); andNo. 2 Anthem Inc. (NYSE: ANTM) is seeking to acquire No. 4 Cigna Corp. (NYSE: CI).

    Related: Why the Cost of Obamacare Plans Will Continue to Skyrocket

  • [By Ben Levisohn]

    The Wall Street Journal reported that government regulators are pushing back against Anthem’s (ANTM) purchase of Cigna (CI). California, however, seems to have few issues with the proposed combination of Aetna (AET) andHumana (HUM). Leerink’s Ana Gupte explains:

  • [By Lisa Levin]

    Humana Inc (NYSE: HUM) delivered better than expected results for the third quarter. However, the company’s adjusted EPS forecast came in below the estimates.

  • [By Ben Levisohn]

    How good were UnitedHealth Group’s (UNH) earnings today? So good its stock has jumped the most in more than six years–and lifted competitors like Humana (HUM), Cigna (CI), Aetna (AET), and Anthem (ANTM) as well. Leerink’s Ana Gupte explains why the market is in love with UnitedHealth’s earnings:

  • [By Ben Levisohn]

    Clinton 15 stock basket (DBUSCLNT): UnitedHealth Group (UNH), Humana (HUM), McKesson (MCK), Aecom (ACM), Quanta Services (PWR), ExxonMobil (XOM), Alcoa (AA), NextEra Energy (NEE), Cree (CREE), First Solar (FSLR), Facebook (FB), Netflix (NFLX), Prudential Financial (PRU), Citigroup (C), Union Pacific (UNP).

Best Value Stocks To Own Right Now: Computer Sciences Corporation(CSC)

Advisors’ Opinion:

  • [By Monica Gerson] Related CSC Earnings Scheduled For May 24, 2016 8 Stocks You Should Be Watching Today Computer Sciences' (CSC) CEO Mike Lawrie on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related Earnings Scheduled For May 24, 2016 8 Stocks You Should Be Watching Today Hewlett Packard Enterprise Announces Plans for Tax-Free Spin-Off and Merger of Enterprise … (GuruFocus)

    Some of the stocks that may grab investor focus today are:

  • [By R. Chandrasekaran]

    Some of the outperforming stocks:

    NVDIA Corp (NASDAQ: NVDA) trading up about 5.7 percent with a range between $69.50 and $71.72.
    Amazon.com, Inc. (NASDAQ: AMZN) is gaining about 4 percent. The stock ranged between $770.94 and $787.73.
    Computer Sciences Corporation (NYSE: CSC) is gaining about 3.3 percent with the stock trading between $56.10 and $58.01.
    Microsoft Corporation (NASDAQ: MSFT) is adding about 3 percent with the stock ranging $59.78-$60.52.
    Alphabet Inc (NASDAQ: GOOGL) is gaining about 2.9 percent with the stock trading between $792.90 and $805.
    Intel Corporation (NASDAQ: INTC) is adding approximately 2.9 percent with shares trading in the range of $34.15-$34.60.
    Cisco Systems, Inc. (NASDAQ: CSCO) is gaining about 2.8 percent as the stock traded between $30.61 and $31.05.
    Salesforce.com, inc. (NYSE: CRM) is adding about 2.8 percent with the shares traded in the range of $75.41-$77.00

Best Value Stocks To Own Right Now: HHGregg, Inc.(HGG)

Advisors’ Opinion:

  • [By Daniel B. Kline]

    Regional electronics chain hhgregg (NYSE:HGG) has decided to close 88 stores and three distribution centers as part of its just-filed Chapter 11 bankruptcy protection plans. The company expects to emerge from bankruptcy in about 60 days and has received funding for the reorganization process from a non-disclosed source.

  • [By Peter Graham]

    A long term performance chart shows shares of Aaron’s, Inc basicallyabove break even with Best Buy Co Inc (NYSE: BBY)taking off againwhile small capshhgregg, Inc (NYSE: HGG) and Rent-A-Center Inc (NASDAQ: RCII)have both been sliding in recent years:

  • [By Paul Ausick]

    Hhgregg Inc. (NYSE: HGG) dropped about 53% Tuesday to post a new 52-week low of $0.61 after closing Monday at $1.31. The 52-week high is $2.72. Volume of around 1.5 million was 30% above the daily average of around 2.2 million shares traded. The consumer electronics retailer announced poor preliminary results after markets closed Monday.

  • [By Peter Graham]

    A long term performance chart shows shares of Best Buy Co all over the place,Aaron’s, Inc (NYSE: AAN) coming in flat for investorsandhhgregg, Inc (NYSE: HGG)severely underperforming:

  • [By WWW.THESTREET.COM]

    Just in the past few weeks, Wall Street has seen bankruptcy filings from sporting goods retailer Gander Mountain, RadioShack successor General Wireless Operations, everyday value price department store operator Gordmans Stores (GMAN) and appliances, electronics and furniture retailer HHGregg (HGG) . Last Wednesday, children’s apparel retailer Gymboree cautioned it was running low on cash and may not survive. Sears Holdings Corp. (SHLD) voiced concerns on Tuesday about its ability to stay in business, while women’s apparel chain Bebe (BEBE) is reportedly on the brink of closing all 170 of its stores.

Best Value Stocks To Own Right Now: CVR Partners LP(UAN)

Advisors’ Opinion:

  • [By Robert Rapier]

    Enter CVR Partners LP (NYSE: UAN), the only company in the US to produce fertilizer from petroleum coke (petcoke). Petcoke is a byproduct of petroleum refining, and prices are usually set off coal prices, since these two products compete in the same niche. Thus the same dynamics that currently threaten the distributions of Rentech Nitrogen Partners and Terra Nitrogen Company play in CVR Partners’ favor.

  • [By Lisa Levin]

    In trading on Tuesday, basic materials shares declined by 1.82 percent. Meanwhile, top losers in the sector included CVR Partners LP (NYSE: UAN), down 10 percent, and Resolute Forest Products Inc (NYSE: RFP), down 9 percent.

  • [By Cameron Swinehart]

    Going forward I will be looking to add investments on my watchlist and trim other positions. It will be interesting to see how an overweight commodity portfolio will perform relative to the rest of the market.

     Cost Basis# SharesCurrent Price% of PortfolioCurrent ValueReturnMetal/Miners      Sprott Physical Gold Trust (PHYS)$12.4985$11.043.75%$938.40-13.13%Sprott Physical Silver Trust (PSLV)$7.95125$8.744.37%$1,092.509.04%FreePort-McMoran (FCX)$31.6731$33.874.20%$1,049.976.50%Ishares MSCI Global Gold Miners ETF (RING)$13.0695$10.644.04%$1,010.80-22.74%Energy      Statoil ASA(STO)$21.7940$22.683.63%$907.203.92%Vanguard Natural Resources LLC (VNR)$27.5636$27.874.01%$1,003.321.11%ConocoPhillips (COP)$63.6822.43$71.006.37%$1,592.5310.31%Agriculture      CVR Partner LP (UAN)$26.3630.9$18.932.34%$584.94-39.25%Adecoagro$6.78125$7.443.72%$930.008.87%Archer-Daniels Midland (ADM)$34.8030$37.244.47%$1,117.206.55%Mixed Commodity      Powershares DB Commodity Index (DBC)$26.3540$25.954.15%$1,038.00-1.54%Sprott Resource Corp$3.34400$2.714.34%$1,084.00-23.25%    Total % of portfolio49.40%               Cost Basis12,666.00      Current Value12,348.86      Return-2.50%  Source: Investing For The Future Surge In Commodity Prices

    Disclosure: I am long ADM, FCX, UAN, AGRO, RING, VNR, SCPZF.PK, COP, DBC, PHYS, PSLV. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More…)

Best Value Stocks To Own Right Now: EXCO Resources NL(XCO)

Advisors’ Opinion:

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.